Tag Archives: Myriad

USPTO Subject Matter Eligibility Guidance – 9th May Forum – Outcome and Opportunities

Posted on May 16, 2014 by Warren Woessner

Guest Post from Paul Cole, Lucas & Co., UK As noted in postings in this and other blogs, controversy has been generated by the publication of new USPTO patent eligibility guidance for laws of nature, natural products and natural phenomena (Andrew … Continue reading →

Posted in Forum | Tagged biotechnology, Chakrabarty, DNA, Myriad, Paul Cole, Supreme Court, USPTO, Warren Woessner | 1 Comment

In re Bergstrom – A Lost Precedent That Should Be “Found”

Posted on May 2, 2014 by Warren Woessner

Since I do a lot of commentary, I read a lot of commentary, and have been struck by how the PTO s. 101 Guidelines on “Laws of Nature” have been criticized as if they are free from the constraints of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Bergstrom, bergy, Chakrabarty, Federal Circuit, Judge Lourie, Myriad, USPTO, Warren Woessner | Leave a comment

Oral Arguments – Can Alice Get Out Of “Wonderland”?

Posted on April 1, 2014 by Warren Woessner

And by “Wonderland” I am referring to the maze of hypotheticals and questions that were thrown at Carter G. Phillips by the Justices during his opening argument for Alice Corp. (A copy of the transcript can be found at the … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Alice Corp, biotechnology, CLS Bank, Federal Circuit, intellectual property, ip, Myriad, Patent Law, patents, Supreme Court, Warren Woessner | 1 Comment

USPTO s.101 Guidelines – How to “Eviscerate Patent Law”

Posted on March 27, 2014 by Warren Woessner

On March 19th, the USPTO released 93 slides as training materials to help Examiners navigate the lengthy ”Guidelines for Subject Matter Eligibility Analysis of Claims Reciting or Involving Laws of Nature,” et al. (A copy of the slides is available … Continue reading →